|
Volumn 1, Issue 3, 2006, Pages 297-308
|
SARS coronavirus anti-infectives.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
DNA DIRECTED RNA POLYMERASE;
HELICASE;
INTERFERON;
MONOCLONAL ANTIBODY;
PROTEINASE INHIBITOR;
ANIMAL;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
PATHOGENICITY;
REVIEW;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
VIROLOGY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
DNA HELICASES;
DNA-DIRECTED RNA POLYMERASES;
HUMANS;
INTERFERONS;
PROTEASE INHIBITORS;
SARS VIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
|
EID: 39549088348
PISSN: 1574891X
EISSN: None
Source Type: Journal
DOI: 10.2174/157489106778777637 Document Type: Review |
Times cited : (13)
|
References (131)
|